Leadership Overview
Mankind Pharma has 7 executives leading key functions including strategy, operations, special projects, finance, human resources, and corporate leadership.
Focused on delivering accessible healthcare solutions, Mankind Pharma maintains a commitment to manufacturing high-quality pharmaceutical products across diverse therapeutic categories to improve patient outcomes globally.
Focused on delivering accessible healthcare solutions, Mankind Pharma maintains a commitment to manufacturing high-quality pharmaceutical products across diverse therapeutic categories to improve patient outcomes globally.
Leadership Roles at Mankind Pharma
Saurav Singh - Chief Executive Officer
Saurav Singh, the Chief Executive Officer at Mankind Pharma, directs the overarching corporate strategy and long-term vision for the organization. Overseeing the integration of pharmaceutical manufacturing processes, the Chief Executive Officer ensures alignment between research initiatives and market demands across the antibiotic, antifungal, and cardiovascular portfolios. This leadership role involves constant evaluation of competitive landscapes to maintain a strong market position within the Indian healthcare sector. By fostering innovation in drug development, Saurav Singh drives the company toward sustainable growth and operational excellence. The Chief Executive Officer coordinates with the board to prioritize resource allocation, ensuring that manufacturing capabilities meet the evolving needs of patients. Ultimately, Singh secures the company's reputation as a leader in the pharmaceutical industry through rigorous quality standards and strategic expansion into new therapeutic segments.
Ashutosh Dhawan - Senior President-Global Chief Financial Officer
Ashutosh Dhawan, the Senior President-Global Chief Financial Officer at Mankind Pharma, manages the financial health and fiscal strategy of the entire organization. Overseeing global capital allocation, the Senior President-Global Chief Financial Officer ensures that investments in manufacturing and research yield maximum returns. This leadership role involves monitoring financial performance across all therapeutic categories, including anthelmintics and erectile dysfunction treatments. By maintaining rigorous financial controls, Ashutosh Dhawan drives the company's ability to fund future growth and infrastructure upgrades. The Senior President-Global Chief Financial Officer collaborates with executive leadership to align budgetary goals with the company's broader mission of accessible healthcare. Through the precise management of fiscal resources, Dhawan supports the stability and expansion of the company's international footprint. Ultimately, the Senior President-Global Chief Financial Officer secures the financial foundation necessary for sustained market leadership.
Arjun Juneja - Chief Operating Officer
Arjun Juneja, the Chief Operating Officer at Mankind Pharma, manages the daily execution of manufacturing operations and supply chain logistics. Overseeing the production of gastrointestinal, NSAID, and dermal products, the Chief Operating Officer optimizes facility output to ensure consistent product availability. This leadership role involves streamlining internal workflows to enhance efficiency across all manufacturing units. By implementing advanced process controls, Arjun Juneja directly impacts the scalability of the company's diverse pharmaceutical offerings. The Chief Operating Officer collaborates with production teams to maintain strict adherence to safety and quality protocols, ensuring that every batch meets regulatory requirements. Through the continuous improvement of operational systems, Juneja supports the company's mission to provide affordable medicine. Ultimately, the Chief Operating Officer maintains the integrity of the supply chain to support robust market distribution.
Abhishek Anand - Chief Operating Officer, Special Projects
Abhishek Anand, the Chief Operating Officer, Special Projects at Mankind Pharma, directs high-priority initiatives focused on market expansion and technological integration. Overseeing the development of specialized therapeutic categories, the Chief Operating Officer, Special Projects ensures that unique product lines receive the necessary focus for successful commercialization. This leadership role involves managing cross-functional teams to execute complex projects that fall outside standard operational workflows. By identifying emerging opportunities in the pharmaceutical sector, Abhishek Anand drives the company toward diversification and increased market share. The Chief Operating Officer, Special Projects coordinates with research and development departments to accelerate the launch of new formulations. Through the strategic management of these critical projects, Anand enhances the company's ability to address unmet medical needs. Ultimately, the Chief Operating Officer, Special Projects secures long-term competitive advantages through targeted innovation.
Atish Majumdar - Senior President
Atish Majumdar, the Senior President at Mankind Pharma, directs the strategic oversight of key business units and market segments. Overseeing the commercial performance of diverse product portfolios, the Senior President ensures that sales and marketing efforts align with the company's mission of providing affordable healthcare. This leadership role involves coordinating with regional teams to expand the reach of pharmaceutical offerings into new territories. By analyzing market trends, Atish Majumdar drives the development of effective commercial strategies that enhance brand presence. The Senior President collaborates with other executives to ensure that product availability meets the needs of healthcare providers and patients. Through the management of these critical business functions, Majumdar supports the company's growth trajectory and market impact. Ultimately, the Senior President secures the company's position as a trusted provider of essential medicines through consistent commercial execution.
Prakash Agarwal - President
Prakash Agarwal, the President at Mankind Pharma, directs the implementation of corporate policies and the management of core business operations. Overseeing the integration of various therapeutic divisions, the President ensures that the company maintains its focus on delivering high-quality pharmaceutical solutions. This leadership role involves facilitating communication between departments to streamline decision-making processes. By monitoring the performance of key product lines, Prakash Agarwal drives the company toward achieving its annual growth targets. The President collaborates with the executive team to refine the company's approach to market challenges and opportunities. Through the oversight of daily business activities, Agarwal ensures that the organization remains agile and responsive to the needs of the healthcare industry. Ultimately, the President secures the operational continuity required to uphold the company's reputation for excellence in the pharmaceutical sector.
Prateek Dubey - Global Chief Human Resources Officer
Prateek Dubey, the Global Chief Human Resources Officer at Mankind Pharma, directs the talent acquisition and organizational development strategies across all regions. Overseeing the cultivation of a high-performance culture, the Global Chief Human Resources Officer ensures that the workforce possesses the technical expertise required for complex pharmaceutical manufacturing. This leadership role involves designing training programs that align with the company's commitment to quality and innovation. By fostering an environment of professional growth, Prateek Dubey drives employee engagement and retention across the organization. The Global Chief Human Resources Officer collaborates with department heads to ensure that staffing levels support the production of antibiotics and other essential medications. Through the implementation of robust human capital policies, Dubey strengthens the company's operational capacity. Ultimately, the Global Chief Human Resources Officer secures the talent pipeline necessary for achieving long-term corporate objectives.
Explore Leadership Teams in Manufacturing
Teva Pharmaceutical Industries Ltd. is a global biopharmaceutical leader focused on improving health outcomes for patients worldwide. Enabled by a world-class generics business, Teva develops, manufactures, and delivers a broad portfolio of medicines, including complex generics, biosimilars, innovative therapies, and pharmacy brands. The company is dedicated to addressing unmet patient needs by advancing scientific research, expanding access to quality medicines, and streamlining the delivery of treatments -from established generics to cutting-edge therapeutic solutions.
Company Leadership JC
ML
YK
GM
Abbott is a global healthcare company that develops and delivers a broad range of medical technologies, diagnostics, nutrition products, and branded generic medicines. The company is focused on improving health outcomes and helping people live healthier lives across all stages of life. Its mission centers on creating innovative solutions that address important medical needs, including chronic disease management, cardiovascular care, diabetes care, and pain management.
Company Leadership FS
RG
CP
CA
Bliss GVS Pharma Limited is a global pharmaceutical company specializing in the manufacturing of a wide range of pharmaceutical products, including capsules, creams, injections, and various healthcare items. The company is recognized as the world's largest manufacturer of suppositories and pessaries, operating world-class facilities that prioritize quality and efficiency. Their mission focuses on discovering and rediscovering pharmaceutics to enhance well-being while increasing the accessibility of pharmaceuticals worldwide. The intended clients include healthcare providers and consumers seeking reliable and effective pharmaceutical solutions.
Company Leadership VD
DS
VR
AM
At Curium, we have a singular focus – to develop, manufacture and supply world-class radiopharmaceutical products around the globe. We strive to innovate further in nuclear diagnostics and therapies so we can enhance the lives of people with cancer.
Every day we see the impact that our treatments offer and the potential they have to provide a world beyond cancer and other debilitating conditions. We continue to push boundaries and reach new heights in everything we do, supported by significant investment into new technologies and therapies.
Company Leadership TG
JP
KE
MF